# Matthias Löhr

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthias-lohr/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,435 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 80 |
| i10-index | 294 |
| Last Known Institution | Sanford Health |
| OpenAlex ID | https://openalex.org/A5067118869 |
| ORCID iD | https://orcid.org/0000-0002-7647-198X |
| Works | 798 |

## Researcher papers

- [International Consensus Diagnostic Criteria for Autoimmune Pancreatitis](https://scholariq.org/papers/international-consensus-diagnostic-criteria-for-autoimmune-pancreatitis/)
- [International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease](https://scholariq.org/papers/international-consensus-guidance-statement-on-the-management-and-treatment-of/)
- [United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)](https://scholariq.org/papers/united-european-gastroenterology-evidence-based-guidelines-for-the-diagnosis-and/)
- [Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis](https://scholariq.org/papers/long-term-outcomes-of-autoimmune-pancreatitis-a-multicentre-international/)
- [European experts consensus statement on cystic tumours of the pancreas](https://scholariq.org/papers/european-experts-consensus-statement-on-cystic-tumours-of-the-pancreas/)
- [Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis](https://scholariq.org/papers/chymotrypsin-c-ctrc-variants-that-diminish-activity-or-secretion-are-associated/)
- [Variants in CPA1 are strongly associated with early onset chronic pancreatitis](https://scholariq.org/papers/variants-in-cpa1-are-strongly-associated-with-early-onset-chronic-pancreatitis/)
- [Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes](https://scholariq.org/papers/clinical-profile-of-autoimmune-pancreatitis-and-its-histological-subtypes/)
- [A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis](https://scholariq.org/papers/a-degradation-sensitive-anionic-trypsinogen-prss2-variant-protects-against/)
- [European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations](https://scholariq.org/papers/european-guideline-on-igg4-related-digestive-disease-ueg-and-sgf-evidence-based/)
- [Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis](https://scholariq.org/papers/recommendations-from-the-united-european-gastroenterology-evidence-based/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Sanford Health](https://scholariq.org/institutions/sanford-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.